|
Volumn 11, Issue 2, 2002, Pages 389-400
|
Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD34 ANTIGEN;
FLT3 LIGAND;
THROMBOPOIETIN;
CD135 ANTIGEN;
FLT3 LIGAND PROTEIN;
FLT3 PROTEIN, HUMAN;
MEMBRANE PROTEIN;
ONCOPROTEIN;
PROTEIN TYROSINE KINASE;
ANTIGEN EXPRESSION;
ARTICLE;
CELL COUNT;
CELL CULTURE;
CELL DIFFERENTIATION;
CELL MATURATION;
CELL PROLIFERATION;
CELL SURVIVAL;
CELL VIABILITY;
CONTROLLED STUDY;
GROWTH RATE;
HEMATOPOIETIC STEM CELL;
HUMAN;
HUMAN CELL;
MEGAKARYOCYTE;
MEGAKARYOPOIESIS;
MODEL;
PLOIDY;
PRIORITY JOURNAL;
STEM CELL;
BONE MARROW CELL;
CULTURE MEDIUM;
CULTURE TECHNIQUE;
CYTOLOGY;
DRUG EFFECT;
DRUG POTENTIATION;
ERYTHROID PRECURSOR CELL;
HEMATOPOIESIS;
ANTIGENS, CD34;
BONE MARROW CELLS;
CELL COUNT;
CELL CULTURE TECHNIQUES;
CELL DIFFERENTIATION;
CULTURE MEDIA, SERUM-FREE;
DRUG SYNERGISM;
ERYTHROID PROGENITOR CELLS;
FMS-LIKE TYROSINE KINASE 3;
HEMATOPOIESIS;
HUMANS;
MEGAKARYOCYTES;
MEMBRANE PROTEINS;
PROTO-ONCOGENE PROTEINS;
RECEPTOR PROTEIN-TYROSINE KINASES;
THROMBOPOIETIN;
|
EID: 0036223207
PISSN: 15258165
EISSN: None
Source Type: Journal
DOI: 10.1089/152581602753658574 Document Type: Article |
Times cited : (11)
|
References (35)
|